tDCS in Chronic Migraine With Medication Overuse (Edisom)

NCT04228809 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2020-02-17

No results posted yet for this study

Summary

Transcranial direct current stimulation (tDCS) was suggested to provide beneficial effects in chronic migraine (CM), a condition often associated with medication overuse (MO) for which no long-term therapy is available.

Conditions

  • Migraine Disorders
  • Medication Overuse Headache

Interventions

DEVICE

tDCS

transcranial direct current stimulation

Sponsors & Collaborators

  • University of Milano Bicocca

    collaborator OTHER
  • Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-01
Primary Completion
2017-06-30
Completion
2018-05-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04228809 on ClinicalTrials.gov